John Bencich Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Bencich.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Bencich. John Bencich is CEO in ACHIEVE LIFE SCIENCES, INC. ($ACHV) and CFO in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and CFO & COO in ACHIEVE LIFE SCIENCES, INC. ($OGXI) and V.P. and CFO in Trubion Pharmaceuticals, Inc ($TRBN).
Latest Insider Trading Transactions of John Bencich
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CEO | Option Exercise | A | 13.09 | 60,000 | 785,400 | 60,000 | |
| Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CEO | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 69 | 0 | 68 | |
| Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Payment of Exercise | F | 8.95 | 33 | 295 | 141 | 174 to 141 (-18.97 %) |
| Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Buy | M | 0.00 | 69 | 0 | 174 | 105 to 174 (+65.71 %) |
| Jan 30 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 0.56 | 200,000 | 112,000 | 200,000 | |
| Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 1,370 | 0 | 2,740 | |
| Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Payment of Exercise | F | 1.88 | 408 | 767 | 2,101 | 2.5 K to 2.1 K (-16.26 %) |
| Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Buy | M | 0.00 | 1,370 | 0 | 2,509 | 1.1 K to 2.5 K (+120.28 %) |
| Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 1.42 | 10,000 | 14,200 | 10,000 | |
| Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 1.42 | 30,000 | 42,600 | 30,000 | |
| Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 28 | 0 | 0 | |
| Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Payment of Exercise | F | 1.16 | 9 | 10 | 1,139 | 1.1 K to 1.1 K (-0.78 %) |
| Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Buy | M | 0.00 | 28 | 0 | 1,148 | 1.1 K to 1.1 K (+2.50 %) |
| Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 2.56 | 50,000 | 128,000 | 50,000 | |
| Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 28 | 0 | 28 | |
| Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 45 | 0 | 0 | |
| Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 1,370 | 0 | 4,110 | |
| Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Payment of Exercise | F | 2.78 | 458 | 1,273 | 1,120 | 1.6 K to 1.1 K (-29.02 %) |
| Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Buy | M | 0.00 | 1,443 | 0 | 1,578 | 135 to 1.6 K (+1,068.89 %) |
| Jul 30 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 3.37 | 25,000 | 84,250 | 25,000 | |
| Jul 30 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 3.37 | 25,000 | 84,250 | 25,000 | |
| Sep 12 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO | Option Exercise | M | 0.00 | 454 | 0 | 455 | |
| Sep 12 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO | Payment of Exercise | F | 3.09 | 149 | 460 | 1,358 | 1.5 K to 1.4 K (-9.89 %) |
| Sep 12 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO | Buy | M | 0.00 | 454 | 0 | 1,507 | 1.1 K to 1.5 K (+43.11 %) |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO | Option Exercise | A | 4.57 | 274,000 | 1,252,180 | 274,000 | |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO | Option Exercise | A | 0.00 | 54,800 | 0 | 54,800 | |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | M | 0.00 | 3,125 | 0 | 6,250 | |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Payment of Exercise | F | 0.63 | 1,021 | 643 | 11,588 | 12.6 K to 11.6 K (-8.10 %) |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Buy | M | 0.00 | 3,125 | 0 | 12,609 | 9.5 K to 12.6 K (+32.95 %) |
| Aug 23 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
| Aug 23 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Sell | S | 0.57 | 1,380 | 787 | 9,484 | 10.9 K to 9.5 K (-12.70 %) |
| Aug 23 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Buy | M | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | A | 0.85 | 112,500 | 95,625 | 112,500 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | M | 0.00 | 3,125 | 0 | 9,375 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Sell | S | 0.83 | 834 | 692 | 5,864 | 6.7 K to 5.9 K (-12.45 %) |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Buy | M | 0.00 | 3,125 | 0 | 6,698 | 3.6 K to 6.7 K (+87.46 %) |
| Aug 20 2015 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| Aug 20 2015 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Sell | S | 2.76 | 1,427 | 3,939 | 3,573 | 5 K to 3.6 K (-28.54 %) |
| Aug 20 2015 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Buy | M | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | A | 1.86 | 25,000 | 46,500 | 25,000 | |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
| Oct 28 2010 | TRBN | Trubion Pharmaceut ... | Bencich John | V.P. and CFO | Option Exercise | D | 3.82 | 25,000 | 95,500 | 0 | |
| Oct 28 2010 | TRBN | Trubion Pharmaceut ... | Bencich John | V.P. and CFO | Option Exercise | D | 5.78 | 10,000 | 57,800 | 0 | |
| Oct 28 2010 | TRBN | Trubion Pharmaceut ... | Bencich John | V.P. and CFO | Option Exercise | D | 1.33 | 14,000 | 18,620 | 0 | |
| Oct 28 2010 | TRBN | Trubion Pharmaceut ... | Bencich John | V.P. and CFO | Option Exercise | D | 8.98 | 4,350 | 39,063 | 0 | |
| Oct 28 2010 | TRBN | Trubion Pharmaceut ... | Bencich John | V.P. and CFO | Option Exercise | D | 19.08 | 12,000 | 228,960 | 0 | |
| Feb 01 2010 | TRBN | Trubion Pharmaceut ... | Bencich John | V.P. and CFO | Option Exercise | A | 3.82 | 25,000 | 95,500 | 25,000 |
Page: 1